2Kolodziejczyk.B,Duleba AJ,Spaczynski Rz,et al.Metformin therapy decreases hyperan drogenism and hyperinsulinemia in women with polycystic ovary syndrome[J].Fertil Steril,2000,73(6):1 149～1 154.
2Pasquali R , Gambineri A , Biscotti D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary sy
3Homburg R, Orvieto R, Bar-Hava I, et al. Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome[J]. Hum Reprod, 1996,11(4): 716-719.
4Vermeulen A, Verclonck L, Kautman JM,et al. A critical evaluation of simple methods for the estimation of free testerone in serum[J]. J Clin Endocrinol Metab ,1999, 84(10):3666-3672.
5De Leo V, La Marca A, Orvieto R, et al. Effect of metformin on insulin-like growth factor-1 and IGF binding protein-1 in polycystic ovary syndrome[J]. J Clin Endocrinol Metab,2000,85(4):1598-1600.
6Verma S, Mather K, Dumont AS, et al. Pharmacological modulation of insulin resistance and hyperinsulinemia in polycystic ovary syndrome[J]. The Endocrinologist , 1998,8(6): 418-424.
7El Orabi H, Ghalia AA, Khalifa A, et al. Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome[J]. Clin Biochem ,1999, 32(1) : 71-75.
9Branigan EF, Estes MA. Treatment of chronic anovulatio-on resistant to clomiphenecitrate (cc) by using oral contraceptive ovarian suppression followed by repeat(CC), treatment [J] . Fertil,2005,71 (3) : 544- 546.
